Documentos relacionados

1. Paget disease of bone - an update.
2. Unusual mid-shaft fractures during long-term bisphosphonate therapy.
3. Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
4. Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones?
5. Therapeutic options: an evidence-based approach to prevention and treatment of osteoporosis.
6. Pharmaceutical care issues encountered by post-menopausal osteoporotic women prescribed bisphosphonates.
7. Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative review.
8. Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.
9. Safety and effectiveness of risedronate in Paget's disease of bone: postmarketing surveillance study in Japan.
10. Role of alendronate and risedronate in preventing and treating osteoporosis.